FierceBiotech's 2013 Fierce 15
This year's Fierce 15 offers some bright prospects from some great biotech minds. You'll find people--like serial entrepreneur and MIT scientist Bob Langer--offering bold if not radical technology from new companies like Moderna, and a whole slate of Big Pharma companies either already jumping in the game or looking to find out more.Some of this year's crop of biotechs should do fine.
Some of them won't. Anybody who tries to pick only winners among private biotechs is destined to fail. What we are sure of is that everyone in this year's group is trying to do something significant about serious diseases. And they stand a chance of doing well by doing good.
You can read full text of report here.